|Day Low/High||2.01 / 2.18|
|52 Wk Low/High||0.60 / 2.90|
Get a head start on searching through ASCO abstracts with these 10 summaries.
Expands Global Erivedge Patient Access and Commercial Opportunity
-- Management to Host Conference Call Today at 9:00 a.m. EDT --
Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Looking for undervalued stocks? Value investors look for opportunities to buy stocks that are trading at significant discounts to their [...]
Brings Over 20 Years of Experience in Oncology Clinical Practice and Cancer Research With Expertise in Precision Approaches to Cancer Therapies
Conference Call to Discuss Results and Provide 2013 Outlook Today at 9:00 a.m. EST
Curis Earns $350,000 in Milestone Payments From The Leukemia & Lymphoma Society
IND Filed to Begin Phase I Clinical Testing of CUDC-907
Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility.
Curis (Nasdaq:CRIS) has been downgraded by TheStreet Ratings from from a hold to sell.
Study to Test Debio 0932 in Patients With Advanced Non-Small Cell Lung Cancer
Curis (Nasdaq:CRIS) has been upgraded by TheStreet Ratings from a sell to hold.
Roche and Curis' drug is the first approved therapy for advanced basal cell carcinoma.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.